iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

ANG Lifesciences India consolidated net profit declines 79.52% in the September 2022 quarter

15 Nov 2022 , 11:37 AM

Net profit of ANG Lifesciences India declined 79.52% to Rs 2.63 crore in the quarter ended September 2022 as against Rs 12.84 crore during the previous quarter ended September 2021. Sales declined 33.13% to Rs 59.82 crore in the quarter ended September 2022 as against Rs 89.46 crore during the previous quarter ended September 2021.

Particulars Quarter Ended
? Sep. 2022 Sep. 2021 % Var.
Sales 59.82 89.46 -33
OPM % 16.13 22.19
PBDT 6.50 18.31 -65
PBT 4.39 17.11 -74
NP 2.63 12.84 -80

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.